| UniProt ID | SSBP2_HUMAN | |
|---|---|---|
| UniProt AC | P81877 | |
| Protein Name | Single-stranded DNA-binding protein 2 | |
| Gene Name | SSBP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 361 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | ||
| Protein Sequence | MYGKGKSNSSAVPSDSQAREKLALYVYEYLLHVGAQKSAQTFLSEIRWEKNITLGEPPGFLHSWWCVFWDLYCAAPERRETCEHSSEAKAFHDYSAAAAPSPVLGNIPPGDGMPVGPVPPGFFQPFMSPRYPGGPRPPLRIPNQALGGVPGSQPLLPSGMDPTRQQGHPNMGGPMQRMTPPRGMVPLGPQNYGGAMRPPLNALGGPGMPGMNMGPGGGRPWPNPTNANSIPYSSASPGNYVGPPGGGGPPGTPIMPSPADSTNSGDNMYTLMNAVPPGPNRPNFPMGPGSDGPMGGLGGMESHHMNGSLGSGDMDSISKNSPNNMSLSNQPGTPRDDGEMGGNFLNPFQSESYSPSMTMSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MYGKGKSN -------CCCCCCCC | 10.06 | - | |
| 4 | Ubiquitination | ----MYGKGKSNSSA ----CCCCCCCCCCC | 45.75 | - | |
| 6 | Acetylation | --MYGKGKSNSSAVP --CCCCCCCCCCCCC | 50.37 | - | |
| 6 | Ubiquitination | --MYGKGKSNSSAVP --CCCCCCCCCCCCC | 50.37 | - | |
| 9 | Phosphorylation | YGKGKSNSSAVPSDS CCCCCCCCCCCCCCH | 27.11 | - | |
| 14 | Phosphorylation | SNSSAVPSDSQAREK CCCCCCCCCHHHHHH | 43.21 | - | |
| 21 | Ubiquitination | SDSQAREKLALYVYE CCHHHHHHHHHHHHH | 33.24 | - | |
| 25 | Phosphorylation | AREKLALYVYEYLLH HHHHHHHHHHHHHHH | 8.72 | 22817900 | |
| 27 | Phosphorylation | EKLALYVYEYLLHVG HHHHHHHHHHHHHHC | 5.82 | 18080319 | |
| 38 | Phosphorylation | LHVGAQKSAQTFLSE HHHCCHHHHHHHHHH | 17.33 | 22210691 | |
| 44 | Phosphorylation | KSAQTFLSEIRWEKN HHHHHHHHHHHHHCC | 27.13 | 24719451 | |
| 130 | Asymmetric dimethylarginine | FQPFMSPRYPGGPRP CCCCCCCCCCCCCCC | 42.86 | - | |
| 136 | Asymmetric dimethylarginine | PRYPGGPRPPLRIPN CCCCCCCCCCCCCCC | 49.06 | - | |
| 140 | Asymmetric dimethylarginine | GGPRPPLRIPNQALG CCCCCCCCCCCCCCC | 48.36 | - | |
| 158 | Phosphorylation | GSQPLLPSGMDPTRQ CCCCCCCCCCCCCCC | 46.87 | 28787133 | |
| 161 (in isoform 5) | Phosphorylation | - | 44.97 | 27251275 | |
| 166 (in isoform 5) | Phosphorylation | - | 49.20 | 22210691 | |
| 170 (in isoform 5) | Phosphorylation | - | 35.74 | 22210691 | |
| 192 | Phosphorylation | VPLGPQNYGGAMRPP CCCCCCCCCCCCCCC | 16.22 | 19658100 | |
| 233 | O-linked_Glycosylation | NANSIPYSSASPGNY CCCCCCCCCCCCCCC | 17.67 | 30379171 | |
| 234 | O-linked_Glycosylation | ANSIPYSSASPGNYV CCCCCCCCCCCCCCC | 27.24 | 30379171 | |
| 236 | O-linked_Glycosylation | SIPYSSASPGNYVGP CCCCCCCCCCCCCCC | 34.98 | 30379171 | |
| 308 | Phosphorylation | ESHHMNGSLGSGDMD CCCCCCCCCCCCCHH | 25.26 | - | |
| 316 | Phosphorylation | LGSGDMDSISKNSPN CCCCCHHHCCCCCCC | 23.32 | 26074081 | |
| 318 | Phosphorylation | SGDMDSISKNSPNNM CCCHHHCCCCCCCCC | 29.72 | 26074081 | |
| 321 | Phosphorylation | MDSISKNSPNNMSLS HHHCCCCCCCCCCCC | 32.51 | 23927012 | |
| 326 | Phosphorylation | KNSPNNMSLSNQPGT CCCCCCCCCCCCCCC | 30.67 | 23927012 | |
| 328 | Phosphorylation | SPNNMSLSNQPGTPR CCCCCCCCCCCCCCC | 26.55 | 23927012 | |
| 329 | Phosphorylation | PNNMSLSNQPGTPRD CCCCCCCCCCCCCCC | 58.31 | 27251275 | |
| 333 | Phosphorylation | SLSNQPGTPRDDGEM CCCCCCCCCCCCCCC | 23.10 | 23927012 | |
| 336 | Phosphorylation | NQPGTPRDDGEMGGN CCCCCCCCCCCCCCC | 70.26 | 27251275 | |
| 341 | Phosphorylation | PRDDGEMGGNFLNPF CCCCCCCCCCCCCCC | 24.48 | 27251275 | |
| 350 | Phosphorylation | NFLNPFQSESYSPSM CCCCCCCCCCCCCCC | 28.96 | 26074081 | |
| 352 | Phosphorylation | LNPFQSESYSPSMTM CCCCCCCCCCCCCCC | 35.84 | 26074081 | |
| 353 | Phosphorylation | NPFQSESYSPSMTMS CCCCCCCCCCCCCCC | 22.13 | 26074081 | |
| 354 | Phosphorylation | PFQSESYSPSMTMSV CCCCCCCCCCCCCCC | 21.56 | 26074081 | |
| 356 | Phosphorylation | QSESYSPSMTMSV-- CCCCCCCCCCCCC-- | 22.42 | 26074081 | |
| 358 | Phosphorylation | ESYSPSMTMSV---- CCCCCCCCCCC---- | 15.61 | 26074081 | |
| 360 | Phosphorylation | YSPSMTMSV------ CCCCCCCCC------ | 18.60 | 26055452 | |
| 362 | Phosphorylation | PSMTMSV-------- CCCCCCC-------- | 27251275 | ||
| 368 | Phosphorylation | V-------------- C-------------- | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SSBP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SSBP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SSBP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| I36RA_HUMAN | IL36RN | physical | 16189514 | |
| RBTN2_HUMAN | LMO2 | physical | 17437998 | |
| TOM1_HUMAN | TOM1 | physical | 21988832 | |
| LDB1_HUMAN | LDB1 | physical | 26186194 | |
| ISL2_HUMAN | ISL2 | physical | 26186194 | |
| ISL1_HUMAN | ISL1 | physical | 26186194 | |
| SSBP4_HUMAN | SSBP4 | physical | 26186194 | |
| SSBP3_HUMAN | SSBP3 | physical | 26186194 | |
| CL18A_HUMAN | CLEC18A | physical | 26186194 | |
| LMO4_HUMAN | LMO4 | physical | 26186194 | |
| LHX4_HUMAN | LHX4 | physical | 26186194 | |
| PIN1_HUMAN | PIN1 | physical | 21516116 | |
| SSBP3_HUMAN | SSBP3 | physical | 28514442 | |
| SSBP4_HUMAN | SSBP4 | physical | 28514442 | |
| ISL2_HUMAN | ISL2 | physical | 28514442 | |
| LDB1_HUMAN | LDB1 | physical | 28514442 | |
| LMO4_HUMAN | LMO4 | physical | 28514442 | |
| CL18A_HUMAN | CLEC18A | physical | 28514442 | |
| ISL1_HUMAN | ISL1 | physical | 28514442 | |
| LHX4_HUMAN | LHX4 | physical | 28514442 | |
| ARHGA_HUMAN | ARHGEF10 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-321 AND THR-333, ANDMASS SPECTROMETRY. | |